We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Top Sens. Target Drug Cos.' Pay-For-Delay Deals

Law360 (February 4, 2009, 12:00 AM EST) -- Two influential U.S. senators have introduced legislation that would outlaw what they call anti-competitive payments made by brand-name pharmaceutical companies to generics makers that resolve patent fights by delaying the availability...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.